ADXN Q1 2024 Earnings Biotech Reports Net Loss Amid Clinical Pipeline Progress IMVT Q1 2026 Earnings EPS Misses Estimates Stock Slightly Positive Amid Development Progress ACCS Q1 2026 Earnings EPS Misses Estimates as Company Faces Headwinds Acrivon Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Allegion ALLE Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Operational Challenges SHG Q4 2025 Earnings EPS Misses Expectations by Wide Margin